Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hamps BioBOM:544312 -2.17%13 Days Inventory is 291.05 as of Mar. 2026, which is 137% above its 10-year median of 122.76. GuruFocus rates BOM:544312 with a GF Score™ of 13/100. The stock has 4 warning signs investors should review. Among 496 Healthcare Providers & Services companies, Hamps Bio ranks worse than 96.37% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Hamps Bio's Average Total Inventories for the
six
months ended in Mar. 2026 was ₹25.53 Mil. Hamps Bio's Cost of Goods Sold for the
six
months ended in Mar. 2026 was ₹16.01 Mil.
Hence, Hamps Bio's Days Inventory for the
six
months ended in Mar. 2026 was 291.05.
The historical rank and industry rank for Hamps Bio's Days Inventory or its related term are showing as below:
BOM:544312'
s Days Inventory Range Over the Past 10 Years
Min: 73.4 Med: 122.76 Max: 329.38
Current: 287.83
During the past 5 years, Hamps Bio's highest Days Inventory was 329.38. The lowest was 73.40. And the median was 122.76.
BOM:544312's Days Inventory is ranked worse than 96.37% of 496
companies
in the Healthcare Providers & Services industry
Industry Median: 29.175
vs BOM:544312: 287.83
Hamps Bio's Days Inventory
declined
from Mar. 2025 (507.36) to Mar. 2026 (291.05).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Hamps Bio's Inventory Turnover for the
six
months ended in Mar. 2026 was 0.63.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Hamps Bio's Inventory-to-Revenue for the
six
months ended in Mar. 2026 was 0.57.
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Hamps Bio's Inventory Turnover for the
six
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Hamps Bio's Inventory to Revenue for the
six
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Hamps Bio Days Inventory Related Terms
Hamps Bio Days Inventory Historical Data
* Premium members only.
The historical data trend for Hamps Bio's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Hamps Bio's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hamps Bio Days Inventory vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Hamps Bio's Days Inventory distribution charts can be found below:
* The bar in red indicates where Hamps Bio's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hamps Bio (BOM:544312) has a Days Inventory of 291.05 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Hamps Bio and its competitors. This is 137% above median its historical median of 122.76. Over the past decade, Hamps Bio's Days Inventory has ranged from 73.40 to 329.38. According to the industry distribution chart, Hamps Bio ranks #478 out of 496 companies in the Healthcare Providers & Services industry, placing it in the top 96.4%.
Is Hamps Bio's Days Inventory too high?
Hamps Bio's current Days Inventory of 291.05 is 137% above median its 10-year median of 122.76. Over the past 10 years, this metric has ranged from a low of 73.40 to a high of 329.38. The Healthcare Providers & Services industry median Days Inventory is 29.18. Hamps Bio's value of 291.05 is 897.6% above this industry median. Based on the distribution chart, Hamps Bio ranks #478 out of 496 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Hamps Bio has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Hamps Bio's Days Inventory compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Hamps Bio ranks #478 out of 496 companies for Days Inventory. This places Hamps Bio in the lower half of its industry. The industry median Days Inventory is 29.18. Hamps Bio's value of 291.05 is 897.6% above this benchmark. Historically, Hamps Bio's own Days Inventory has ranged from 73.40 to 329.38 over the past decade. While the company's 10-year median is 122.76 vs. the industry median of 29.18, Hamps Bio has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Healthcare Providers & Services company?
The median Days Inventory among Healthcare Providers & Services companies is 29.18, based on 496 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hamps Bio's current Days Inventory of 291.05 is 897.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Hamps Bio and its competitors. For the Healthcare Providers & Services industry, the median Days Inventory is 29.18 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hamps Bio's current Days Inventory is 291.05, which is 137% above median its own 10-year median of 122.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hamps Bio stock overvalued right now?
Hamps Bio (BOM:544312) has a current Days Inventory of 291.05. The current Days Inventory is 291.05, which is 137% above median its 10-year median of 122.76 and 897.6% above the Healthcare Providers & Services industry median of 29.18. Hamps Bio's overall GF Score™ is 13/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Hamps Bio (BOM:544312), the current Days Inventory is 291.05 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Hamps Bio Ltd is engaged in the ethical marketing and distribution of pharmaceutical formulation products. Its product include tablets, syrups, capsules, injectables, oil, gel and powder used as medicine and nutrition supplements as well as the manufacturing of freeze dried and frozen products such as fruits, vegetables, herbs and flowers. The company segment includes Manufacturing, trading and distribution of Pharmaceutical formulation products and Manufacturing of Freeze dried and frozen products like fruits, vegetables, herbs, flowers, etc. Key revenue is generated from Medicine Products.
13GF Score
Get the complete analysis for BOM:544312
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544312 has been successfully added to your 
